Invo Bioscience Stock Price, News & Analysis (OTCMKTS:IVOB)

$0.19 0.00 (0.00 %)
(As of 12/12/2017 10:53 AM ET)
Previous Close$0.18
Today's RangeN/A
52-Week Range$0.15 - $0.40
VolumeN/A
Average Volume35,946 shs
Market Capitalization$26.89 million
P/E RatioN/A
Dividend YieldN/A
Beta1.75

About Invo Bioscience (OTCMKTS:IVOB)

INVO Bioscience, Inc. is a medical device company. The Company is focused on creating various treatments for patients diagnosed with infertility. The Company's product, the INVOcell, is a medical device used in infertility treatment and is considered as an assisted reproductive technology (ART). INVOcell is an intravaginal culture (IVC) system used for preparing, holding and transferring human gametes or embryos during vaginal in vitro fertilization or intravaginal culture procedures (IVF/IVC). The INVOcell system consists of various components: INVOcell Culture Device, INVOcell Retention Device and INVOcell Holding Block. The INVO Procedure is a fertility treatment option allowing fertilization and early embryo development to take place inside the woman's body. The INVO Procedure is an IVC or in vivo incubation assisted reproduction technique available.

Receive IVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for IVOB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:IVOB
CUSIPN/A
Phone+1-978-8789505

Debt

Debt-to-Equity Ratio-0.03%
Current Ratio0.03%
Quick Ratio0.02%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$50,000.00
Price / Sales538.38
Cash FlowN/A
Price / CashN/A
Book Value($0.03) per share
Price / Book-6.33

Profitability

Trailing EPS($0.01)
Net Income$-2,120,000.00
Net Margins-347.80%
Return on EquityN/A
Return on Assets-367.53%

Miscellaneous

Employees3
Outstanding Shares141,680,000

Invo Bioscience (OTCMKTS:IVOB) Frequently Asked Questions

What is Invo Bioscience's stock symbol?

Invo Bioscience trades on the OTCMKTS under the ticker symbol "IVOB."

How were Invo Bioscience's earnings last quarter?

Invo Bioscience Inc (OTCMKTS:IVOB) issued its quarterly earnings data on Monday, May, 15th. The company reported $0.00 EPS for the quarter. The firm had revenue of $0.05 million for the quarter. View Invo Bioscience's Earnings History.

When will Invo Bioscience make its next earnings announcement?

Invo Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, April, 19th 2018. View Earnings Estimates for Invo Bioscience.

Who are some of Invo Bioscience's key competitors?

Who are Invo Bioscience's key executives?

Invo Bioscience's management team includes the folowing people:

  • Kathleen T. Karloff, Chairman of the Board, President, Chief Executive Officer (Age 61)
  • Robert J. Bowdring, Chief Financial Officer, Treasurer, Secretary, Director (Age 59)
  • Kevin Doody, Director
  • Michael J. Campbell, Independent Director
  • Stephen M. Shum, Independent Director (Age 47)

How do I buy Invo Bioscience stock?

Shares of Invo Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Invo Bioscience's stock price today?

One share of Invo Bioscience stock can currently be purchased for approximately $0.19.

How big of a company is Invo Bioscience?

Invo Bioscience has a market capitalization of $26.89 million and generates $50,000.00 in revenue each year. The company earns $-2,120,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Invo Bioscience employs 3 workers across the globe.

How can I contact Invo Bioscience?

Invo Bioscience's mailing address is 407R Mystic Ave Ste 34C, MEDFORD, MA 02155-6336, United States. The company can be reached via phone at +1-978-8789505 or via email at [email protected]


MarketBeat Community Rating for Invo Bioscience (IVOB)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  48
MarketBeat's community ratings are surveys of what our community members think about Invo Bioscience and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Invo Bioscience (OTCMKTS:IVOB) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Invo Bioscience (OTCMKTS:IVOB) Earnings History and Estimates Chart

Earnings by Quarter for Invo Bioscience (OTCMKTS:IVOB)

Invo Bioscience (OTCMKTS IVOB) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/19/2018        
5/15/2017Q1 2017$0.00$0.05 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Invo Bioscience (OTCMKTS:IVOB) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Invo Bioscience (OTCMKTS:IVOB)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Invo Bioscience (OTCMKTS IVOB)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Invo Bioscience (OTCMKTS IVOB) News Headlines

Source:
DateHeadline
INVO Bioscience Reports Third Quarter 2017 Financial ResultsINVO Bioscience Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 15 at 3:24 AM
INVO Bioscience Appoints Michael J. Campbell and Steven Shum to Its Board of DirectorsINVO Bioscience Appoints Michael J. Campbell and Steven Shum to Its Board of Directors
finance.yahoo.com - October 11 at 4:48 PM
First INVO Babies Born in CaliforniaFirst INVO Babies Born in California
finance.yahoo.com - September 25 at 9:23 AM
Dr. Francisco Arredondo Opens First U.S. INVOcell Center in McAllen, TexasDr. Francisco Arredondo Opens First U.S. INVOcell Center in McAllen, Texas
finance.yahoo.com - September 6 at 7:59 PM
INVO Bioscience Reports Record Second Quarter 2017 Financial ResultsINVO Bioscience Reports Record Second Quarter 2017 Financial Results
finance.yahoo.com - August 11 at 4:37 AM
INVOcell Fertility Treatment Now Offered at the Center for Reproductive Health at Tri-Star Centennial Medical Center in NashvilleINVOcell Fertility Treatment Now Offered at the Center for Reproductive Health at Tri-Star Centennial Medical Center in Nashville
finance.yahoo.com - August 3 at 8:14 PM
Piedmont Reproductive Endocrinology Group in South Carolina Successfully Launches INVOcellPiedmont Reproductive Endocrinology Group in South Carolina Successfully Launches INVOcell
finance.yahoo.com - August 2 at 1:34 AM
Houston Fertility Center to Begin Offering INVOcell Procedure to Patients in Southeast TexasHouston Fertility Center to Begin Offering INVOcell Procedure to Patients in Southeast Texas
finance.yahoo.com - July 19 at 10:40 PM
The Atlantic Magazine Publishes Article on Breakthrough IVF Treatment by INVO BioscienceThe Atlantic Magazine Publishes Article on Breakthrough IVF Treatment by INVO Bioscience
finance.yahoo.com - July 14 at 4:44 AM
INVO BIOSCIENCE, INC. Files SEC form 10-K, Annual ReportINVO BIOSCIENCE, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 17 at 6:14 PM
INVO BIOSCIENCE, INC. Files SEC form 8-K, Changes in Registrants Certifying Accountant, Amendments to Articles of InINVO BIOSCIENCE, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Amendments to Articles of In
biz.yahoo.com - January 6 at 6:39 PM
INVO BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal OfficersINVO BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - September 26 at 5:47 PM
INVO BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsINVO BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - November 3 at 11:59 AM

SEC Filings

Invo Bioscience (OTCMKTS:IVOB) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Invo Bioscience (OTCMKTS IVOB) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.